MedTrace Logo

Prospective, Single-arm, Multi Centre Observations Ultimaster Des Registry

NCT02188355 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 37000

Last updated 2019-10-08

No results posted yet for this study

Summary

The e-Ultimaster will further validate the safety and efficacy of Ultimaster DES system in unselected patients representing everyday clinical practice. Also the study will assess the impact of non-compliance with dual antiplatelet therapy, one month after stent implementation (frequently observed in every day clinical practice), on stent thrombosis.

Conditions

Sponsors & Collaborators

  • Terumo Europe N.V.

    lead INDUSTRY

Principal Investigators

  • Vladimir Borovicanin, MD · Terumo Europe

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Argentina
  • Armenia
  • Austria
  • Bangladesh
  • Belarus
  • Belgium
  • Brazil
  • Bulgaria
  • Chile
  • Colombia
  • Czechia
  • Egypt
  • Estonia
  • France
  • Georgia
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Japan
  • Jordan
  • Kazakhstan
  • Kuwait
  • Lebanon
  • Lithuania
  • Malaysia
  • Mexico
  • Morocco
  • Netherlands
  • North Macedonia
  • Oman
  • Poland
  • Portugal
  • Romania
  • Saudi Arabia
  • Serbia
  • Slovakia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Thailand
  • Tunisia
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • Uzbekistan
  • Vietnam

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02188355 on ClinicalTrials.gov